G Johan A Offerhaus
Overview
Explore the profile of G Johan A Offerhaus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
7318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Schee L, Verbeeck A, Deckers I, Kuijpers C, Offerhaus G, Seerden T, et al.
United European Gastroenterol J
. 2024 Oct;
12(10):1429-1439.
PMID: 39476327
Background: Lymphovascular invasion (LVI) plays an important role in determining the risk of lymph node metastasis (LNM) in T1 colorectal cancer (CRC) patients and influencing treatment decisions and patient outcomes....
2.
Baars M, Floor E, Sinha N, Ter Linde J, van Dam S, Amini M, et al.
iScience
. 2024 Aug;
27(8):110550.
PMID: 39165839
Patients with long-standing inflammatory bowel disease (IBD) face an increased risk of developing colitis-associated cancer (CAC). Although IBD-induced prolonged inflammation seems to be involved in CAC pathogenesis, the specific molecular...
3.
Huisman J, Dang H, Moons L, Backes Y, Dik V, Groen J, et al.
United European Gastroenterol J
. 2023 Jun;
11(6):551-563.
PMID: 37300377
Background: The role of radiological staging and surveillance imaging is under debate for T1 colorectal cancer (CRC) as the risk of distant metastases is low and imaging may lead to...
4.
Leicher L, Huisman J, van Grevenstein W, Didden P, Backes Y, Offerhaus G, et al.
Ann Surg
. 2022 Feb;
275(5):933-939.
PMID: 35185125
Objective: The aim of this study was to evaluate the safety and efficacy of a modified CAL-WR. Summary Background Data: The use of segmental colectomy in patients with endoscopically unresectable...
5.
Hackeng W, Van Beek D, Kok A, van Emst M, Morsink F, van Treijen M, et al.
Am J Surg Pathol
. 2021 Sep;
46(2):159-168.
PMID: 34560682
Patients with multiple endocrine neoplasia 1 syndrome (MEN1) often develop multifocal duodenopancreatic neuroendocrine tumors (dpNETs). Nonfunctional pancreatic neuroendocrine tumors (PanNETs) and duodenal gastrinomas are the most frequent origins of metastasis....
6.
Overwater A, van Munster S, Offerhaus G, Seldenrijk C, Raicu G, Koch A, et al.
Gastrointest Endosc
. 2021 May;
94(4):832-842.e2.
PMID: 33974941
Background And Aims: Early esophageal squamous cell neoplasia (ESCN) is preferably treated with en-bloc endoscopic resection. Ablation might be an alternative for flat ESCN, but ESCN extension along the epithelial...
7.
Hackeng W, Brosens L, Kim J, OSullivan R, Sung Y, Liu T, et al.
Gut
. 2021 Apr;
71(5):961-973.
PMID: 33849943
Objective: Recent studies have found aristaless-related homeobox gene (ARX)/pancreatic and duodenal homeobox 1 (PDX1), alpha-thalassemia/mental retardation X-linked (ATRX)/death domain-associated protein (DAXX) and alternative lengthening of telomeres (ALT) to be promising...
8.
Hackeng W, Dreijerink K, Offerhaus G, Brosens L
Mol Cancer Res
. 2021 Mar;
19(6):946-949.
PMID: 33771883
Patients with multiple endocrine neoplasia 1 (MEN1) syndrome have a germline mutation in the gene. Loss of the wild-type allele can initiate endocrine tumorigenesis. Microscopic and macroscopic pituitary, parathyroid, and...
9.
Machlowska J, Kapusta P, Szlendak M, Bogdali A, Morsink F, Wolkow P, et al.
Oncol Lett
. 2021 Mar;
21(5):348.
PMID: 33747205
Gastric cancer (GC) is the fourth most common cause of cancer-associated death. Based on the age at diagnosis, GC is divided into early-onset GC (EOGC; ≤45 years) and conventional GC...
10.
Dang H, van Pelt G, Haasnoot K, Backes Y, Elias S, Seerden T, et al.
United European Gastroenterol J
. 2021 Feb;
PMID: 33566452
Background: Current risk stratification models for early invasive (T1) colorectal cancer are not able to discriminate accurately between prognostic favourable and unfavourable tumours, resulting in over-treatment of a large (>80%)...